Results summary | View all lists in L2L MDB | View all genes in L02B.profile.ud50 |
Down-regulated at least 1.4-fold following treatment of HepG2 human hepatocellular carcinoma cells with carcinogen benzo(a)pyrene (BaP), at any time point from 6-48 hours and at any concentration from 0.25-5 microM. enrichment: 14.45-fold |
![]() |
![]() | |||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | ![]() |
![]() |
Description |
214616_AT | HIST1H3E | ![]() |
![]() |
histone cluster 1, H3e | |||||||||
202818_S_AT | TCEB3 | R | ![]() |
![]() |
transcription elongation factor B (SIII), polypeptide 3 (110kDa, elongin A) | ||||||||
214334_X_AT | DAZAP2 | ![]() |
![]() |
DAZ associated protein 2 | |||||||||
201108_S_AT | THBS1 | D | X | C | ![]() |
![]() |
thrombospondin 1 |